MEND

CompanyUnited States

MEND develops one asset, in phase 2 (MEND Repair & Recover in femoral fractures). Mostly supplement acting on proteostasis; based in the United States.

1
Asset
Furthest stage
Phase 2
0
Trials
1
Signal

Pipeline

1
  • MEND Repair & Recover

    Essential amino acid-based nutritional supplement supporting skeletal muscle protein synthesis.

    Phase 2, Supplement, Proteostasis, femoral fractures, fragility fracture

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials1
  • Signals1
  • Similar companies6

Intelligence